Cited 0 times in Scipus Cited Count

Metabolomic Profiles Predict Diabetes Remission after Bariatric Surgery

DC Field Value Language
dc.contributor.authorHa, J-
dc.contributor.authorJang, M-
dc.contributor.authorKwon, Y-
dc.contributor.authorPark, YS-
dc.contributor.authorPark, DJ-
dc.contributor.authorLee, JH-
dc.contributor.authorLee, HJ-
dc.contributor.authorHa, TK-
dc.contributor.authorKim, YJ-
dc.contributor.authorHan, SM-
dc.contributor.authorHan, SU-
dc.contributor.authorHeo, Y-
dc.contributor.authorPark, S-
dc.date.accessioned2022-12-07T05:53:18Z-
dc.date.available2022-12-07T05:53:18Z-
dc.date.issued2020-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/23120-
dc.description.abstractBACKGROUND: Amino acid metabolites (AAMs) have been linked to glucose homeostasis and type 2 diabetes (T2D). We investigated whether (1) baseline AAMs predict T2D remission 12 months after bariatric surgery and (2) whether AAMs are superior for predicting T2D remission postoperatively compared with existing prediction models. METHODS: Among 24 participants undergoing bariatric surgery, 16 diabetes-related AAMs were quantified at baseline and postoperative 3 and 12 months. Existing prediction models included the ABCD, DiaRem, and IMS models. RESULTS: Baseline L-dihydroxyphenylalanine (L-DOPA) (areas under receiver operating characteristic curves (AUROC), 0.92; 95% confidence interval (CI), 0.75 to 1.00) and 3-hydroxyanthranilic acid (3-HAA) (AUROC, 0.85; 95% CI, 0.67 to 1.00) better predicted T2D remission 12 months postoperatively than the ABCD model (AUROC, 0.81; 95% CI, 0.54 to 1.00), which presented the highest AUROC value among the three models. The superior prognostic performance of L-DOPA (AUROC at 3 months, 0.97; 95% CI, 0.91 to 1.00) and 3-HAA (AUROC at 3 months, 0.86; 95% CI, 0.63 to 1.00) continued until 3 months postoperatively. CONCLUSIONS: The AAM profile predicts T2D remission after bariatric surgery more effectively than the existing prediction models.-
dc.language.isoen-
dc.titleMetabolomic Profiles Predict Diabetes Remission after Bariatric Surgery-
dc.typeArticle-
dc.identifier.pmid33271740-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760750-
dc.subject.keywordbariatric surgery-
dc.subject.keywordmetabolic surgery-
dc.subject.keyworddiabetes-
dc.subject.keywordamino acid-
dc.subject.keywordmetabolomics-
dc.contributor.affiliatedAuthorHan, SU-
dc.type.localJournal Papers-
dc.identifier.doi10.3390/jcm9123897-
dc.citation.titleJournal of clinical medicine-
dc.citation.volume9-
dc.citation.number12-
dc.citation.date2020-
dc.citation.startPage3897-
dc.citation.endPage3897-
dc.identifier.bibliographicCitationJournal of clinical medicine, 9(12). : 3897-3897, 2020-
dc.identifier.eissn2077-0383-
dc.relation.journalidJ020770383-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Surgery
Files in This Item:
33271740.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse